Bio-Rad Laboratories target price raised to $440 from $390
BIO•RBC raised its target price for Bio-Rad Laboratories to $440 from $390.
Related News
Egetis recommends public cash offer from ANI Pharmaceuticals
ANIP•
Corpay, Inc.: KBW raises price target to $525 from $470
CPAY•
Business news digest for November 5 includes CVS Health split plan
CVS•
Evotec 9M 2026 operating loss more than doubles to EUR 254.78 million
EVO•
DOF secures Petrobras contract extension for Skandi Olinda through January 2028
PBR•